The 2026 BCT ASM serves as a critical engine for clinical progress by providing a collaborative workspace where the research community transitions from theory to practice. The full and extensive program will include three days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research, and other research developments.
